PriceTargets.com logo

BlackRock Health Sciences Trust - BME Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$38.74 As of 04/18/2024 01:00 AM ET
▼ -0.13 (-0.33%)

This chart shows the closing price for BME by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BlackRock Health Sciences Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BME and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BME

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for BlackRock Health Sciences Trust in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $38.74.

This chart shows the closing price for BME for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in BlackRock Health Sciences Trust. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/29/2020National Bank FinancialDowngradeSector PerformLow
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
BlackRock Health Sciences Trust logo
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Read More

Today's Range

Now: $38.74
Low: $38.67
High: $39.01

50 Day Range

MA: $41.25
Low: $38.45
High: $42.65

52 Week Range

Now: $38.74
Low: $35.53
High: $43.20

Volume

22,860 shs

Average Volume

33,682 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

0.06%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of BlackRock Health Sciences Trust?

The following Wall Street sell-side analysts have issued stock ratings on BlackRock Health Sciences Trust in the last twelve months:
View the latest analyst ratings for BME.

What is the current price target for BlackRock Health Sciences Trust?

0 Wall Street analysts have set twelve-month price targets for BlackRock Health Sciences Trust in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for BlackRock Health Sciences Trust in the next year.
View the latest price targets for BME.

What is the current consensus analyst rating for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BME.

What other companies compete with BlackRock Health Sciences Trust?

Other companies that are similar to BlackRock Health Sciences Trust include abrdn Global Dynamic Dividend, abrdn Global Premier Properties Fund, Abrdn Healthcare Opportunities Fund, Abrdn Income Credit Strategies Fund and Abrdn World Healthcare Fund. Learn More about companies similar to BlackRock Health Sciences Trust.

How do I contact BlackRock Health Sciences Trust's investor relations team?

BlackRock Health Sciences Trust's physical mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company's listed phone number is (800) 882-0052. The official website for BlackRock Health Sciences Trust is www2.blackrock.com. Learn More about contacing BlackRock Health Sciences Trust investor relations.